CYCLOFLUIDIC
Cyclofluidic is using CyclOpsâ„¢, its proprietary closed-loop structure activity platform, to revolutionise hit and lead optimisation. CyclOpsâ„¢ connects chemistry, purification/analysis, screening and compound design with complex algorithms allowing drug lead molecules to be assayed within minutes, rather than weeks, after they are designed. When combined with the power of flow chemistry, developed in the labs of Prof Steve Ley at Cambridge University, our unique approach puts synthesis, scre... ening and molecular design firmly back together in a single laboratory allowing fast iterative exploration of vast areas of diverse chemical space. CyclOpsâ„¢ is the ultimate lean approach to lead discovery, allowing Cyclofludic to optimise hits in real time, making and screening only those key compounds that progress a hypothesis towards the best possible lead molecules.
CYCLOFLUIDIC
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Welwyn Garden City, Hertford, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cyclofluidic.co.uk
Total Employee:
11+
Status:
Active
Contact:
+441707 358706
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins AJAX Libraries API
Newest Events participated
Participated in Angels in MedCity Pitching Event Apr-2017
on 2017-04-26 as exhibitor
Official Site Inspections
http://www.cyclofluidic.co.uk
- Host name: 104.207.141.197.vultrusercontent.com
- IP address: 104.207.141.197
- Location: Elk Grove Village United States
- Latitude: 42.0048
- Longitude: -87.9954
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60007
More informations about "Cyclofluidic"
Fluidic Protein Discovery – Biotech supplies
This technique is crucial for diagnosing conditions like multiple myeloma and amyloidosis (World Health Organization – WHO). Considerations for Selecting Precast Protein Plus Gels 1. Gel …See details»
Cyclofluidic - Crunchbase Company Profile & Funding
Organization. Cyclofluidic . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Pfizer and UCB set up joint venture with funding from UK …
Oct 21, 2008 The UK government is co-funding the world’s largest pharmaceutical company Pfizer Inc and its partner, UCB Pharma, to found a start-up Cyclofluidic Ltd to develop new …See details»
Cyclofluidic Ltd. Information - RocketReach
Cyclofluidic is an emerging disruptive technology company. Our unique microfluidic integrated synthesis and screen platform, CyclOpsâ„¢ reduces the design-synthesis-screen cycle time by …See details»
Cyclofluidic Ltd - VentureRadar
"Cyclofluidic is using its proprietary microfluidic drug discovery platform, CIDP, to revolutionise hit and lead optimisation. Our unique approach puts synthetic chemistry, screening and molecular …See details»
CYCLOFLUIDIC LIMITED - LinkedIn
CYCLOFLUIDIC LIMITED | 15 followers on LinkedIn. CYCLOFLUIDIC LIMITED is a biotechnology company based out of 9400 GARSINGTON ROAD OXFORD BUSINESS …See details»
Pfizer and UCB Announce Formation of New Company …
Oct 20, 2008 The UK Government's Technology Strategy Board has helped facilitate this innovative arrangement between Pfizer and UCB and will continue to support Cyclofluidic by …See details»
The Cyclofluidic Story | Science - AAAS
May 30, 2019 The recent post here on automation in chemistry (especially medicinal chemistry) is a good intro for this paper in ACS Med. Chem. Letters.It's from David Parry, who led …See details»
Contact Us – Fluidic Protein Discovery - cyclofluidic.co.uk
Recent Posts. Prenatal Risk Factors for Developmental Delay; Eukaryote vs Prokaryote; Endocytosis and Exocytosis; Development of antigen sandwich ELISA to detect interferon …See details»
HitGen Announces Collaboration in Drug Discovery with …
Apr 17, 2015 For further details about Cyclofluidic Ltd please contact: Cyclofluidic Ltd. Dr Dave Parry, COO +44 (0)1707 358676. [email protected]. About HitGen. HitGen is a privately …See details»
Cyclofluidic Ltd.:Acquisition,Acquisition Analysis & Reports ...
Discovery Company profile page for Cyclofluidic Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Pfizer, UCB team to launch Cyclofluidic, drug research and …
Oct 21, 2008 Pfizer, UCB team to launch Cyclofluidic, drug research and development company . Alaric DeArment. 10/21/2008. LONDON Pfizer and ...See details»
Cyclofluidic to Accelerate Flow Chemistry, Biology Processes
Nov 6, 2008 According to reports, the UK government's Technology Strategy Board has helped to facilitate this arrangement between Pfizer and UCB and will continue to support Cyclofluidic …See details»
Pfizer and UCB Form New Company to Speed Drug Discovery
Oct 23, 2008 Pfizer and UCB formed a technology company named Cyclofluidic with the aim of accelerating the drug-discovery process. News. All News Top News Industry News …See details»
Top Cyclofluidic Alternatives, Competitors - CB Insights
Explore Cyclofluidic's alternatives and competitors. How VCs Use CB Insights. Go to the video gallery . →See details»
Company Information - RocketReach
[email protected]: 100.0%. Email Verification Tool Instantly check any Microsoft email. Get free lookups per month. Verify Top Cyclofluidic Ltd. Employees Chris Selway Chief …See details»
2nd SCI/RSC Symposium on Continuous Processing and Flow …
Sep 25, 2013 Session 4: Scale up and processing Chair: Dave Parry, Cyclofluidic Plenary lecture 3: Opportunities and challenges in development and scale up of continuous chemical …See details»
Working at Fluidic Protein Discovery - Glassdoor
See what employees say it's like to work at Fluidic Protein Discovery. Salaries, reviews, and more - all posted by employees working at Fluidic Protein Discovery.See details»
Cyclofluidic Announces First Fully Automated Lead Discovery …
Feb 1, 2012 Scientists used the company’s proprietary microfluidic system to design, make and screen potential drug molecules active against thrombin, a target associated with stroke.See details»
Ubiquigent and Cyclofluidic Enter Into Collaboration to Build …
Agreement combines ubiquitin focused biology expertise with proprietary chemistry platform to identify small molecule libraries that target the ubiquitin system. Ubiquigent Limited, a …See details»